<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>Table 1</label>
 <caption>
  <p>Current licensed anti-protozoal vaccines and those in the pipeline or at the pilot scale.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Target host</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Target parasite</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Vaccine</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Formulation</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Preventive mechanism</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Status</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Human</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Plasmodium falciparum</italic> pre-erythrocytic
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">RTS,S</td>
    <td valign="top" align="left" rowspan="1" colspan="1">CPS central repeat fused to hepatitis B surface antigen adjuvanted with ASO1 adjuvant (monophosphoryl lipid A and the QS21 saponin)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibits sporozoite motility and invasion of hepatocytes</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase III trials</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Dog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Leishmania</italic> (L.) 
     <italic>infantum chagasi</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Leishmune
     <sup>®</sup>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">FML antigen of 
     <italic>Leishmania</italic> (L.) 
     <italic>donovani</italic> and QS21 acylated and deacylated saponins
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Prevents infection; blocks transmission; increases CD4+, CD8+, and CD21+ lymphocyte rates</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Licensed</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Dog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Leishmania</italic> (L.) 
     <italic>infantum</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Canileish
     <sup>®</sup>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">LiESP/QA-21 (
     <italic>L</italic>. (L.) 
     <italic>infantum</italic> Excreted Secreted Proteins (ESP) and the purified extract of 
     <italic>Quillaja saponaria</italic> QA-21)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Increases Th1 IgG and IgM responses, leishmanicidal activity of macrophages, and expression of iNOS and NO</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Licensed</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Dog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Leishmania</italic> (L.) 
     <italic>infantum chagasi</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Leishtec
     <sup>®</sup>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Recombinant protein A2 of amastigotes of 
     <italic>L</italic>. (L.) 
     <italic>donovani</italic> and saponin
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">A2 is expressed in amastigotes and involved in resistance</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Licensed</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Dog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Leishmania</italic> (L.) 
     <italic>infantum</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Letifend
     <sup>®</sup>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Poly-protein Q composed of Lip2a, Lip2b, LipP0 and the H2A histone of 
     <italic>L</italic>. (L.) 
     <italic>infantum</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Increases IgG2 and DTH response</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Licensed</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Human</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Leishmania</italic> (L.) 
     <italic>infantum</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">LeishF3</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NH36-SMT antigen (Nucleoside hydrolase NH36 of 
     <italic>Leishmania</italic> (L.) 
     <italic>donovani</italic>, the main antigen of Leishmune
     <sup>®</sup>, the sterol 24-c-methyltransferase (SMT) from 
     <italic>L</italic>. (L.) 
     <italic>infantum</italic>), and glucopyranosyl lipid A-stable oil-in-water nanoemulsion
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Increases the secretion of IFN-γ, TNF-α, IL-2, IL-5, and IL-10 in response to the vaccine antigen.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase I trials</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Dogs and cats</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <italic>Giardia lamblia</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Giardiavax
     <sup>®</sup>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inactivated trophozoites of 
     <italic>Giardia lamblia</italic>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Prevention and treatment of clinical signs and reduction of cyst shedding</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Licensed</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
